A multicentre, double blind, parallel group, phase IIa clinical trial to assess the efficacy and safety of Cpn10 administered as twice weekly intravenous injections in subjects with rheumatoid arthritis.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors CBio
- 29 Aug 2011 Actual initiation date (Aug 2005) added as reported by Australian New Zealand Clinical Trials Registry.
- 29 Aug 2011 Additional trial identifiers (ACTRN12606000041550, 001022) identified, inclusion and exclusion criteria amended and addititional trial centers identified as reported by Australian New Zealand Clinical Trials Registry.
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000041550).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History